Seattle Genetics Inc (NASDAQ:SGEN)

55.35
Delayed Data
As of Feb 23
 +1.57 / +2.92%
Today’s Change
45.31
Today|||52-Week Range
71.32
+3.46%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues109.1M108.2M135.3M129.6M
 
 
 
 
 
Cost of Goods Sold7.1M6.9M8.0M7.8M
 
 
 
 
 
Depreciation And Amortization4.8M5.4M6.2M7.9M
 
 
 
 
 
 
Operating ExpensesGross Income97.3M95.8M121.1M113.9M
 
 
 
 
 
General Expenses156.6M155.1M153.3M159.0M
 
 
 
 
 
Research And Development118.2M114.4M113.6M110.5M
 
 
 
 
 
Total Operating Expenses168.4M167.5M167.5M174.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-59.3M-59.3M-32.2M-45.0M
 
 
 
 
 
Extraordinary Credit0.000.0078.7M0.00
 
 
Extraordinary Charge0.000.000.00-42.9M
 
 
Other Expenses-672.0K2.9M2.7M0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-60.0M-56.4M50.0M-87.1M
 
 
 
 
 
Income Taxes0.000.000.00-27.9M
 
 
Net Income-60.0M-56.4M50.0M-59.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS142.5M142.8M143.4M144.1M
 
 
 
 
 
Shares To Calculate EPS Diluted142.5M142.8M148.1M144.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.42-$0.39$0.34-$0.41
 
 
 
 
 
EPS Diluted-$0.42-$0.39$0.34-$0.41